There is an ongoing discussion whether African American individuals with subnephrotic-range proteinuria, with an FSGS lesion on biopsy associated with only segmental foot process effacement, and with the APOL1 risk alleles should receive a diagnosis of FSGS or should alternatively by diagnosed with APOL1-associated nephropathy. This evidence concerns the gene APOL1 and Nephropathy.